Apellis Pharmaceuticals, Inc.
USD41.03
+0.00 (+0.00%)
CEO
Cedric Francois
IPO Date
2017-11-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$41.05
Prev. Close
$41.03
Day Low
$41.03
Day High
$41.05
52W Low
$16.61
52W High
$41.14
Market Cap
$5.25B
Volume
28.64M
| -20.0 |
| 31 Dec 2023 | FY | 85.2% | -133.3% | -271.8% | -67.0% | 0.57 | 3.10 | -13.4 |
| 31 Dec 2022 | FY | 92.5% | -864.7% | -383.9% | -85.8% | 0.66 | 4.29 | -8.4 |
| 31 Dec 2021 | FY | 92.2% | -1121.3% | -375.7% | -84.6% | 1.06 | 6.25 | -5.3 |
| 31 Dec 2020 | FY | 90.0% | -137.6% | -168.6% | -35.9% | 1.85 | 7.15 | -12.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -890.2% | -78.3% | 4.59 | 5.67 | -6.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -79.2% | -62.6% | 0.17 | 11.89 | -5.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -34.2% | -28.0% | 0.18 | 27.77 | -14.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -114.0% | -98.9% | 0.00 | 7.52 | -9.4 |
| -13.4 |
| 30 Sept 2025 | Q3 | 94.7% | 47.0% | 53.8% | 20.4% | 1.18 | 3.54 | 3.3 |
| 30 Jun 2025 | Q2 | 92.1% | -23.6% | -27.0% | -5.1% | 3.01 | 3.77 | -12.9 |
| 31 Mar 2025 | Q1 | 79.4% | -55.3% | -56.2% | -11.4% | 2.86 | 4.08 | -7.4 |
| 31 Dec 2024 | Q4 | 80.8% | -17.1% | -15.9% | -4.1% | 2.06 | 4.25 | -27.2 |
| 30 Sept 2024 | Q3 | 83.0% | -29.2% | -24.2% | -6.4% | 1.98 | 4.36 | -15.6 |
| 30 Jun 2024 | Q2 | 88.2% | -18.9% | -14.2% | -4.2% | 1.80 | 5.08 | -29.9 |
| 31 Mar 2024 | Q1 | 88.0% | -38.5% | -24.9% | -8.0% | 0.72 | 3.77 | -27.6 |
| 31 Dec 2023 | Q4 | 86.4% | -60.5% | -45.5% | -11.2% | 0.57 | 3.10 | -20.5 |